| 000 | 01794cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 101209s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.23.M.Sc.2010.Ah.R | ||
| 100 | 0 | _aAhmed Mohamed Mahmoud Mostafa Abdelakher | |
| 245 | 1 | 0 |
_aRetrospective study of Second line chemotherapy in adult soft - tissue sarcomas single centre experience (NEMROCK) / _cAhmed Mohamed Mahmoud Mostafa Abdelakher ; Supervised May Hussein Gaber , Iman Abdelhady Hassan , Amr Yehia Sakr |
| 246 | 1 | 5 | _aدراسة مرجعية فى علاج الورم الخبيث للانسجة الرخوه فى البالغين باستخدام الخط الثانى للعلاج الكيميائى |
| 260 |
_aCairo : _bAhmed Mohamed Mahmoud Mostafa Abdelakher , _c2010 |
||
| 300 |
_a101P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology-clinical | ||
| 520 | _aBackground : Soft - tissue sarcomas (STS) are rare malignant mesenchymal tumors . For most patients the aetiology is unknown . Diagnostic methods include biopsy .Imaging methods immunohisto-chemistry and cytogenetics . The goal of treatment for soft tissue sarcomas is to optimize oncologic outcome and maximize functional restoration by surgery radiotherapy and chemotherapy | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aSecond line chemotherapy | |
| 653 | 4 | _aSingle centre experience | |
| 653 | 4 | _aSoft - tissue sarcomas | |
| 700 | 0 |
_aAmr Yehia Sakr , _eSupervisor |
|
| 700 | 0 |
_aIman Abdelhady Hassan , _eSupervisor |
|
| 700 | 0 |
_aMay Hussein Gaber , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c32193 _d32193 |
||